Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has reached pandemic proportions with negative impacts on global health, the world economy and human society. The clinical picture of COVID-19, and the fact that Angiotensin converting enzyme 2 (ACE2) is a receptor of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Discov Today
Autors principals: Latil, Mathilde, Camelo, Serge, Veillet, Stanislas, Lafont, René, Dilda, Pierre J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2021
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7888990/
https://ncbi.nlm.nih.gov/pubmed/33609783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.02.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars